KRG-81075-32989
1 vaccination
2 coded responses
9 check-ins
2 free-text entries
0 call cases
- Sex
- Male
- Age at first dose
- 0-4
- ZIP prefix
- 662 / KS
- Registered
- 2022-06-28
- Relationship
- Child or adolescent in my care
- Guardian
- JRU-17144-65388
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2022-06-25
Dose 1 — Pfizer-BioNTech
-
2022-06-28
Registered in v-safe
-
2022-06-28
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Good · Site: Pain · NoneUnder 3 check-in
- 2022-06-29
-
2022-06-30
Health check-in — days 1–6 daily, dose 1, under 3Feeling: Fair · Irritability/crying, Loss of appetiteUnder 3 check-in
-
2022-07-01
Survey response — days 1–6 daily, dose 1, under 3MedDRA: Cough, Secretion discharge — Feeling: FairFree text: Cough and mucousMedDRA releases: 2024-11 · check-in free text available
- 2022-07-02
- 2022-07-09
-
2022-09-24
Survey response — 3 months, dose 1, under 3MedDRA: Nasopharyngitis — Feeling: GoodFree text: Cold symptomsMedDRA releases: 2024-11 · check-in free text available
- 2022-12-24
- 2023-06-25
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-06-25 | Pfizer-BioNTech | No |
Free text
Release 12 (Under 3) — days 1–6 daily, dose 1, under 3
Systemic reaction (other): Cough and mucous
Release 12 (Under 3) — 3 months, dose 1, under 3
Symptoms: Cold symptoms
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasopharyngitis | · | · | ✓ |
| SRO | Cough | · | · | ✓ |
| SRO | Secretion discharge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release